Quantcast

Latest gabapentin Stories

2010-05-28 06:40:00

MELBOURNE, Australia and SAN FRANCISCO, May 28 /PRNewswire/ -- Relevare Pharmaceuticals Ltd. will present its recent Phase IIa proof-of-concept clinical trial data and extension study results for CNSB015 (flupirtine), its lead repositioned compound, at the Third International Congress on Neuropathic Pain on May 27 -30 in Athens, Greece. Dr. Kate Cherry, MD, PhD, Head of the Neuropathy and Drug Toxicity Group at the Burnet Institute in Melbourne, Australia will share the results of the...

2010-05-17 11:00:00

NEW YORK, May 17 /PRNewswire-FirstCall/ -- In a first-of-a-kind collaboration between academia and industry, Pfizer Inc. (NYSE: PFE) will give scientists at Washington University School of Medicine in St. Louis unprecedented access to information regarding more than 500 pharmaceuticals and pharmaceutical candidates in a partnership that focuses on discovering new uses for existing compounds. (Logo: http://photos.prnewswire.com/prnh/20100416/PFIZERLOGO ) Under the five-year agreement...

2010-03-25 17:50:00

NEW YORK, March 25 /PRNewswire/ -- Following a month-long trial in United States District Court in Boston, a federal jury awarded Plaintiffs Kaiser Foundation Health Plan, Inc. and Kaiser Foundation Hospitals over $47 million in damages, before mandatory trebling and interest. The jury found that Pfizer fraudulently marketed Neurontin for unapproved uses -- including bipolar disorder, neuropathic pain, and migraine -- for which Pfizer misrepresented the drug's efficacy. Kaiser's lead...

2010-03-22 07:00:00

WALTHAM, Mass., March 22 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a novel formulation of Pfizer's Neurontin that is dosed once a day would earn a 50 percent patient share in the treatment of postherpetic neuralgia, according to surveyed U.S. neurologists. In Europe, such an agent would earn a patient share of 40 percent, according to surveyed European neurologists. Such a drug would...

2010-02-02 09:18:00

JERUSALEM, Feb. 2 /PRNewswire-FirstCall/ -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today the availability of new resources to support the recently introduced Tjet® injector system, a needle-free device designed to deliver Teva's TEV-TROPIN® [somatropin (rDNA origin) for injection] brand human growth hormone (hGH) to children who have growth failure due to inadequate secretion of normal endogenous growth hormone. The...

2009-12-07 20:42:01

Despite government warnings about an increased risk of suicidal thoughts and actions while taking antiepileptic drugs, these medications do not appear to be associated with increased risk of suicide attempts in individuals with bipolar disorder, and may have a possible protective effect, according to a report in the December issue of Archives of General Psychiatry, one of the JAMA/Archives journals. Antiepileptic drugs are life-saving for those with seizure disorders and are also used to...

2009-10-13 15:17:12

A Duke University Medical Center researcher who spent years looking for the signals that prompt the brain to form new connections between neurons has found one that may explain precisely how a well-known drug for epilepsy and pain actually works. The finding may also point to new therapies for brain injury and neuropathic pain. The role of neurons in the brain and nervous system is well known, but astrocytes, a different type of brain cell, still are largely a mystery. Duke scientist Cagla...

2009-10-09 09:15:33

Questions raised about use of antiseizure drug Researchers at the Stanford University School of Medicine have identified a key molecular player in guiding the formation of synapses "” the all-important connections between nerve cells "” in the brain. This discovery, based on experiments in cell culture and in mice, could advance scientists' understanding of how young children's brains develop as well as point to new approaches toward countering brain disorders in adults. The new...

2009-10-01 10:12:00

People who suffer from debilitating neuropathic pain may get more relief and sleep better by combining two commonly-prescribed drugs. A new, federally-funded study by Queen's University researchers has found that taking the drugs together is a more effective treatment than taking either of them individually. When given both an anti-seizure drug (gabapentin) and an antidepressant (nortriptyline), patients suffering from neuropathic pain caused by nerve damage or disease experienced less pain...

2009-09-08 08:54:41

Gabapentin, a drug initially used to treat seizures, improves sleep quality in menopausal women with hot flashes, University of Rochester Medical Center researchers report online and in the September issue of the Journal of Women's Health. Approximately 40 percent of menopausal women experience sleep disruption, often in the form of difficulty with sleep initiation and frequent nighttime awakenings. The study is the first to show sustained benefits in sleep quality from gabapentin, which...


Word of the Day
holluschickie
  • A 'bachelor seal'; a young male seal which is prevented from mating by its herd's older males (mated bulls defending their territory).
This comes from the Russian word for 'bachelors.'
Related